Mycophenolate Mofetil Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the comparative bioavailability between
Mycophenolate Mofetil 500 mg Tablets (test) and CellCept® 500 mg tablets (reference), after a
single-dose in healthy subjects under fasting conditions.